Tetrasodium [29H,31H-phthalocyaninetetrasulphonato(6-)-N29,N30,N31,N32]cuprate(4-)

Endpoint summary

Description of key information

ACUTE ORAL
LD50 > 2000 mg/kg bw (female rat); OECD 423, EU Method B.1. tris, EPA OPPTS 870.1100, EPA 712-C-98-190; Mátyás A. (2015)

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records

Reference

Endpoint:

acute toxicity: oral

Type of information:

experimental study

Adequacy of study:

key study

Study period:

12 February 2015 to 18 March 2015

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: Study conducted to GLP in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not affect the quality of the relevant results.

Qualifier:

according to guideline

Guideline:

OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)

Deviations:

no

Qualifier:

according to guideline

Guideline:

EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)

Deviations:

no

Qualifier:

according to guideline

Guideline:

EPA OPPTS 870.1100 (Acute Oral Toxicity)

Deviations:

no

Qualifier:

according to guideline

Guideline:

other: EPA 712-C-98-190

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Test type:

acute toxic class method

Limit test:

yes

Species:

rat

Strain:

other: CRL:(WI)

Sex:

female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Strain: CRL:(WI) (outbred, SPF-quality)
- Source: Charles River Laboratories, Research Models and Services, Germany GmbH, Sandhofer Weg 7, D-97633 Sulzfeld
- Age at study initiation: Approximately 10 weeks old
- Weight at study initiation: 178 to 232 g
- Fasting period: On the night before treatment, the animals were fasted
- Housing: 3 animals/cage in type II polypropylene/polycarbonate.
- Diet (e.g. ad libitum): Animals received ssniff, SM R/M "Autoclavable complete diet for rats and mice- breeding and maintenance” produced by ssniff , Spezialdiäten GmbH, D-59494 Soest Germany (Batch no.: 680 2237 expiry date: March 2015), ad libitum, and tap water from the municipal supply, as for human consumption from a 500 ml bottle, ad libitum. The food is considered not to contain any contaminants that could reasonably be expected to affect the purpose or integrity of the study.
- Acclimation period: 19/20 days


ENVIRONMENTAL CONDITIONS
- Temperature: 19.8 to 22.8 °C
- Humidity: 31 to 70 % (relative)
- Air changes: 15 – 20 air exchanges/hour
- Photoperiod: Lighting period; 12 hours daily, from 6.00 a.m. to 6.00 p.m.

IN-LIFE DATES:
- From: 12 February 2015
- To: 18 March 2015

Route of administration:

oral: gavage

Vehicle:

water

Remarks:

distilled water

Details on oral exposure:

VEHICLE
- Concentration in vehicle: 200 mg/mL
- Amount of vehicle (if gavage): 10 mL/kg bw
- Justification for choice of vehicle:
- Batch number: 2171213

CLASS METHOD
- Rationale for the selection of the starting dose: The initial dose level was selected by the Study Director to be that which is most likely to produce mortality in some of the dosed animals. In the lack of any preliminary toxicological information, 2000 mg/kg bw was selected to be the starting dose.

Doses:

2000 mg/kg bw

No. of animals per sex per dose:

6 females; the test material was administered to two subsequent groups of three female rats

Control animals:

no

Details on study design:

- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observatins were made 30 minutes, 1, 2, 3, 4 and 6 hours after dosing and daily for 14 days thereafter. The body weight was recorded on the day before treatment (Day -1), on the day of the treatment (Day 0) and weekly thereafter.
- Necropsy of survivors performed: Yes
- Other examinations performed: Clinical signs, body weight, organ weights, histopathology, other: Individual observations were performed on the skin, fur, eyes, mucous membranes, respiratory, circulatory, autonomic and central nervous system, somatomotor activity and behaviour pattern. Particular attention was directed to observation of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma.

Statistics:

No statistical analysis was performed as the method used is not intended to allow the calculation of a precise LD50 value.

Sex:

female

Dose descriptor:

LD50

Effect level:

> 2 000 mg/kg bw

Based on:

test mat.

Mortality:

No mortality occurred.

Clinical signs:

other: Acute oral administration of Acid Blue 249 did not caused any test item related toxic effect. Bluish discolouration of the faeces was observed on Day 0, Day 1 and Day 2.

Gross pathology:

There was no evidence of the macroscopic observations at a dose level of 2000 mg/kg bw.

Table 1: Body Weight Data (g):         

DOSE LEVEL: 2000 mg/kg bw, Treatment on Day 0
SEX: FEMALE
Cage No.	Animal Number	Body Weight (g)				Body Weight Gain (g)
		Days
		-1	0	7	14	-1-0	0-7	7-14	-1-14
1	2211	233	217	246	250	-16	29	4	17
	2212	242	232	250	245	-10	18	4	12
	2213	244	228	253	255	-16	25	2	11
2	2214	237	229	257	258	-8	28	1	21
	2215	229	219	243	247	-10	24	4	18
	2216	187	178	207	215	-9	29	8	28
Mean:		228.7	217.2	242.7	246.5	-11.5	25.5	3.8	17.8

 

 

 

Interpretation of results:

not classified

Remarks:

Migrated information Criteria used for interpretation of results: EU

Conclusions:

Under the conditions of this study, the acute oral LD50 value of the test material was found to be above 2000 mg/kg bw in female CRL:(WI) rats.

Executive summary:

The single-dose oral toxicity of the test material was performed according to the acute toxic class method (OECD 423 and Commission Regulation (EC) No 440/2008 of 30 May 2008, B.1.Tris) in CRL:(WI) rats.

Two groups of three female CRL:(WI) rats were treated with the test item at a dose level of 2000 mg/kg bw (Group 1 and Group 2).

A single oral treatment was carried out by gavage for each animal after an overnight food withdrawal. Food was made available again 3 hours after the treatment. The test item was administered formulated in distilled water at a concentration of 200 mg/mL at a dose volume of 10 mL/kg bw.

Initially, three females (Group 1) were treated at a dose level of 2000 mg/kg bw. As no mortality was observed, a confirmatory group (Group 2) was treated at the same dose level. No mortality was observed in the confirmatory group; therefore no further testing was required according to OECD 423 and Commission Regulation (EC) NO 440/2008 of 30 May 2008, B.1.Tris.

Clinical observations were performed at 30 minutes, 1, 2, 3, 4 and 6 hours after dosing and daily for 14 days thereafter. Body weight was measured on Days -1, 0 and 7 and before necropsy. All animals were subjected to a necropsy and a macroscopic examination.

The test material did not cause mortality at a dose level of 2000 mg/kg bw.

Acute oral administration of the test material did not cause any test item related toxic effect. Bluish discolouration of the faeces was observed on Day 0, Day 1 and Day 2.

Body weight gains of the test material treated animals during the study showed no indication of a test item-related effect.

There was no evidence of the macroscopic observations at a dose level of 2000 mg/kg bw.

Under the conditions of this study, the acute oral LD50 value of the test material was found to be above 2000 mg/kg bw in female CRL:(WI) rats.

According to Annex I, Regulation (EC) No. 1272/2008, the test material is unclassified for acute oral exposure.

Endpoint conclusion

Endpoint conclusion:

no adverse effect observed

Dose descriptor:

LD50

Value:

2 000 mg/kg bw

Quality of whole database:

The study was conducted in accordance with standardised guidelines and under GLP conditions. The study was awarded a reliability score of 1 in accordance with the principles for assessing data quality set forth by Klimisch et al. (1997). The quality of the database is therefore considered to be high.

Acute toxicity: via inhalation route

Endpoint conclusion

Endpoint conclusion:

no study available

Acute toxicity: via dermal route

Endpoint conclusion

Endpoint conclusion:

no study available

Additional information

The single-dose oral toxicity of the test material was performed according to the acute toxic class method (OECD 423 and Commission Regulation (EC) No 440/2008 of 30 May 2008, B.1.Tris) in CRL:(WI) rats.

Two groups of three female CRL:(WI) rats were treated with the test item at a dose level of 2000 mg/kg bw (Group 1 and Group 2).

A single oral treatment was carried out by gavage for each animal after an overnight food withdrawal. Food was made available again 3 hours after the treatment. The test item was administered formulated in distilled water at a concentration of 200 mg/mL at a dose volume of 10 mL/kg bw.

Initially, three females (Group 1) were treated at a dose level of 2000 mg/kg bw. As no mortality was observed, a confirmatory group (Group 2) was treated at the same dose level. No mortality was observed in the confirmatory group; therefore no further testing was required according to OECD 423 and Commission Regulation (EC) NO 440/2008 of 30 May 2008, B.1.Tris.

Clinical observations were performed at 30 minutes, 1, 2, 3, 4 and 6 hours after dosing and daily for 14 days thereafter. Body weight was measured on Days -1, 0 and 7 and before necropsy. All animals were subjected to a necropsy and a macroscopic examination.

The test material did not cause mortality at a dose level of 2000 mg/kg bw.

Acute oral administration of the test material did not cause any test item related toxic effect. Bluish discolouration of the faeces was observed on Day 0, Day 1 and Day 2.

Body weight gains of the test material treated animals during the study showed no indication of a test item-related effect.

There was no evidence of the macroscopic observations at a dose level of 2000 mg/kg bw.

Under the conditions of this study, the acute oral LD50 value of the test material was found to be above 2000 mg/kg bw in female CRL:(WI) rats.

According to Annex I, Regulation (EC) No. 1272/2008, the test material is unclassified for acute oral exposure.

Justification for selection of acute toxicity – oral endpoint
Only one study available.

Justification for classification or non-classification

Under the conditions of this study, the acute oral LD50 value of the test material was found to be above 2000 mg/kg bw in female CRL:(WI) rats.

According to Annex I, Regulation (EC) No. 1272/2008, the test material is unclassified for acute oral exposure.